Literature DB >> 31022698

Inflammatory Bowel Disease Susceptibility Gene C1ORF106 Regulates Intestinal Epithelial Permeability.

Paolo Manzanillo1, Maria Mouchess2, Naruhisa Ota2, Bingbing Dai2, Ryan Ichikawa3, Arthur Wuster4, Benjamin Haley5, Gabriela Alvarado2, Youngsu Kwon6, Roger Caothien5, Meron Roose-Girma5, Soren Warming5, Brent S McKenzie6, Mary E Keir3, Alexis Scherl7, Wenjun Ouyang1, Tangsheng Yi1.   

Abstract

Intestinal epithelial cells form a physical barrier that is tightly regulated to control intestinal permeability. Proinflammatory cytokines, such as TNF-α, increase epithelial permeability through disruption of epithelial junctions. The regulation of the epithelial barrier in inflammatory gastrointestinal disease remains to be fully characterized. In this article, we show that the human inflammatory bowel disease genetic susceptibility gene C1ORF106 plays a key role in regulating gut epithelial permeability. C1ORF106 directly interacts with cytohesins to maintain functional epithelial cell junctions. C1orf106-deficient mice are hypersensitive to TNF-α-induced increase in epithelial permeability, and this is associated with increased diarrhea. This study identifies C1ORF106 as an epithelial cell junction protein, and the loss of C1ORF106 augments TNF-α-induced intestinal epithelial leakage and diarrhea that may play a critical role in the development of inflammatory bowel disease.
Copyright © 2018 The Authors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 31022698     DOI: 10.4049/immunohorizons.1800027

Source DB:  PubMed          Journal:  Immunohorizons        ISSN: 2573-7732


  5 in total

Review 1.  Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.

Authors:  Yonghyun Lee; Nobuhiko Kamada; James J Moon
Journal:  Adv Drug Deliv Rev       Date:  2021-10-26       Impact factor: 15.470

Review 2.  Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.

Authors:  Clara Abraham; Maria T Abreu; Jerrold R Turner
Journal:  Gastroenterology       Date:  2022-02-09       Impact factor: 33.883

Review 3.  Pathway paradigms revealed from the genetics of inflammatory bowel disease.

Authors:  Daniel B Graham; Ramnik J Xavier
Journal:  Nature       Date:  2020-02-26       Impact factor: 49.962

Review 4.  The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.

Authors:  Dominika Jakubczyk; Katarzyna Leszczyńska; Sabina Górska
Journal:  Nutrients       Date:  2020-07-02       Impact factor: 5.717

5.  Small-molecule modulators of INAVA cytosolic condensate and cell-cell junction assemblies.

Authors:  Denis Chang; Phi Luong; Qian Li; Jamie LeBarron; Michael Anderson; Lee Barrett; Wayne I Lencer
Journal:  J Cell Biol       Date:  2021-07-12       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.